KrystalBottomMD

Pediatric Hematology & Oncology • Asheville, NC

Pediatric Hem/Onc attending at Mission Hospital

Join to view full profile

Dr. Bottom is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bottom's full profile

Already have an account?

Office
11 Vanderbilt Park Dr
Asheville, NC 28803
Phone+1 828-213-1740

Fax+1 828-213-1742

Education & Training

Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1996
University of South Florida MorsaniResidency, Pediatrics, 1989 - 1992
University of Florida College of MedicineClass of 1989

Certifications & Licensure

NC State Medical License 1996 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Recruiting
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

16 citations
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas
Albert Moghrabi, Henry S. Friedman, David M. Ashley, Krystal S. Bottom, Tracy Kerby
Neurosurgical Focus. 1998-04-15
12 citations
Trilineage hematopoietic toxicity associated with valproic acid therapy.
Krystal S. Bottom, Denise M. Adams, Karen P. Mann, Russell E. Ware
Journal of Pediatric Hematology/oncology. 1997-01-01
56 citations
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Christopher D. Turner, Sridharan Gururangan, James D. Eastwood, Krystal S. Bottom, Melody A. Watral
Neuro-Oncology. 2002-04-01

Press Mentions

North Carolina Boy Holds onto Hope While Battling Rare Brain TumorJuly 7th, 2017

KrystalBottomMD

Dr. Bottom is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.